HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1,3- dihydro- 1- (1- ((4- (6- phenyl- 1H- imidazo(4,5- g)quinoxalin- 7- yl)phenyl)methyl)- 4- piperidinyl)- 2H- benzimidazol- 2- one

inhibits both Akt1 and Akt1; has a synergistic effect against cancer when combined with chloroquine; structure in first source
Also Known As:
1,3-dihydro-PIQPBO; Akt inhibitor VIII
Networked: 10 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Kong, Min: 1 article (10/2019)
2. Shen, Bin: 1 article (10/2019)
3. Sun, Peiyu: 1 article (10/2019)
4. Wu, Lingzhi: 1 article (10/2019)
5. Yu, Congcong: 1 article (10/2019)
6. Zhou, Meihua: 1 article (10/2019)
7. Zhou, Yuehong: 1 article (10/2019)
8. Alfano, Luigi: 1 article (01/2018)
9. Allison, Robert D: 1 article (01/2018)
10. Barone, Daniela: 1 article (01/2018)

Related Diseases

1. Hypertension (High Blood Pressure)
2. Neoplasms (Cancer)
3. Stomach Neoplasms (Stomach Cancer)
4. Mesothelioma
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. RNA (Ribonucleic Acid)
2. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
3. Calcium
4. Long Noncoding RNA
5. Phosphotransferases (Kinase)
6. Etoposide (VP 16)
7. Doxorubicin (Adriamycin)
8. Cisplatin (Platino)
9. Bleomycin (Blenoxane)
10. Lenalidomide (CC 5013)